Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine

Clinical trial NCT00662870 · COMPLETED

Trial details

NCT number: NCT00662870
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Whooping Cough Polio Haemophilus Influenzae Type b

Start date: 2001-05-01
Primary completion: 2004-01-01
Enrollment: 1941

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.